Insider · CIK 0001219015

CLARKE JOHN K

Reports to the SEC for 7 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001219015

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-05-22	ATYRaTYR PHARMA INC · Stock Option (right to buy)A Award	Director	AAward	+24K sh	—	—	24,000
2023-05-17	ATYRaTYR PHARMA INC · Stock Option (right to buy)A Award	Director	AAward	+12K sh	—	—	12,000
2023-04-26	ATYRaTYR PHARMA INCM Exercise/Conversion	Director	MExercise/Conversion	+6,000 sh	—	—	19,797
2023-04-26	ATYRaTYR PHARMA INC · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−6,000 sh	—	—	0
2022-04-26	ATYRaTYR PHARMA INC · Restricted Stock UnitsA Award	Director	AAward	+6,000 sh	—	—	6,000
2021-05-21	ATYRaTYR PHARMA INCS Sale	Director	SSale	−2,500 sh	$4.34	−$10.9K	108,083
2021-04-28	ATYRaTYR PHARMA INC · Stock Option (right to buy)A Award	Director	AAward	+1,428 sh	—	—	1,428
2020-09-02	ATYRaTYR PHARMA INCS Sale	Director	SSale	−7,260 sh	$4.01	−$29.1K	110,583
2020-08-28	ATYRaTYR PHARMA INCS Sale	Director	SSale	−100 sh	$4.00	−$400	117,843
2020-08-27	ATYRaTYR PHARMA INCS Sale	Director	SSale	−5,440 sh	$4.09	−$22.2K	117,943
2020-08-26	ATYRaTYR PHARMA INCS Sale	Director	SSale	−2,200 sh	$4.30	−$9,451.2	123,383
2020-05-06	ATYRaTYR PHARMA INC · Stock Option (right to buy)A Award	Director	AAward	+1,428 sh	—	—	1,428
2019-05-08	ATYRaTYR PHARMA INC · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2018-06-20	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)A Award	Director	AAward	+9,000 sh	—	—	9,000
2018-05-31	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director	SSale	−10K sh	$100.33	−$1.01M	11,091
2018-05-31	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director	SSale	−2,758 sh	$99.38	−$274K	21,133
2018-05-31	ALNYALNYLAM PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+15K sh	$27.28	+$409K	23,891
2018-05-31	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−15K sh	—	—	0
2018-05-31	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director	SSale	−100 sh	$101.97	−$10.2K	8,891
2018-05-31	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director	SSale	−2,100 sh	$101.37	−$213K	8,991
2018-05-15	ATYRaTYR PHARMA INC · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2017-06-02	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)A Award	Director	AAward	+11.3K sh	—	—	11,250
2017-05-09	ATYRaTYR PHARMA INC · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2016-06-03	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)A Award	Director	AAward	+11.3K sh	—	—	11,250
2016-05-24	ATYRaTYR PHARMA INC · Stock Option (right to buy)A Award	Director	AAward	+18K sh	—	—	18,000
2016-01-27	ATYRaTYR PHARMA INC · Stock Option (right to buy)A Award	Director	AAward	+19.4K sh	—	—	19,428
2015-07-08	ATYRaTYR PHARMA INC · Stock Option (right to buy)A Award	Director	AAward	+6,286 sh	—	—	6,286
2015-06-10	MOMENTA PHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director	AAward	+17.8K sh	—	—	176,350
2015-06-01	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)A Award	Director	AAward	+11.3K sh	—	—	11,250
2015-05-12	ATYRaTYR PHARMA INC · Series B-2 Redeemable Convertible Preferred StockC Conversion	Director	CConversion	−4.32M sh	—	—	0
2015-05-12	ATYRaTYR PHARMA INC · Series C Redeemable Convertible Preferred StockC Conversion	Director	CConversion	−2.13M sh	—	—	0
2015-05-12	ATYRaTYR PHARMA INC · Series D Redeemable Convertible Preferred StockC Conversion	Director	CConversion	−1.54M sh	—	—	0
2015-05-12	ATYRaTYR PHARMA INC · Series B Redeemable Convertible Preferred StockC Conversion	Director	CConversion	−3.6M sh	—	—	0
2015-05-12	ATYRaTYR PHARMA INC · Series A Redeemable Convertible Preferred StockC Conversion	Director	CConversion	−2.4M sh	—	—	0
2015-05-12	MOMENTA PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+38.4K sh	$10.44	+$401K	107,523
2015-05-12	MOMENTA PHARMACEUTICALS INCS Sale	Director	SSale	−38.4K sh	$19.96	−$766K	69,123
2015-05-12	MOMENTA PHARMACEUTICALS INCStock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−38.4K sh	—	—	0
2015-05-12	ATYRaTYR PHARMA INCC Conversion	Director	CConversion	+92.3K sh	—	—	104,878
2015-05-12	ATYRaTYR PHARMA INCC Conversion	Director	CConversion	+1.76M sh	—	—	1,758,158
2015-05-12	ATYRaTYR PHARMA INC · Series E Redeemable Convertible Preferred StockC Conversion	Director	CConversion	−894K sh	—	—	0
2013-06-12	VSTMVerastem, Inc.P Purchase	Director	PPurchase	+23.2K sh	$9.60	+$222K	2,329,121
2013-06-11	VSTMVerastem, Inc.P Purchase	Director	PPurchase	+25K sh	$9.22	+$230K	2,305,950
2013-06-11	MOMENTA PHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director	AAward	+17.8K sh	—	—	179,250
2013-06-06	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2013-06-04	VSTMVerastem, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2013-05-13	VSTMVerastem, Inc.P Purchase	Director	PPurchase	+25K sh	$9.73	+$243K	2,280,950
2013-05-01	VSTMVerastem, Inc.P Purchase	Director	PPurchase	+10K sh	$9.66	+$96.6K	2,255,950
2013-04-17	VSTMVerastem, Inc.P Purchase	Director	PPurchase	+5,631 sh	$9.50	+$53.5K	2,245,950
2012-12-18	VSTMVerastem, Inc.P Purchase	Director	PPurchase	+6,193 sh	$7.87	+$48.7K	2,240,319
2012-06-21	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000

Recent filings

Accepted (ET)
May 234
CLARKE JOHN K0000950170-24-064235
SEC(opens sec.gov)
May 194
CLARKE JOHN K0001209191-23-031002
SEC(opens sec.gov)
Apr 284
CLARKE JOHN K0001209191-23-026069
SEC(opens sec.gov)
Apr 284
CLARKE JOHN K0001209191-22-026084
SEC(opens sec.gov)
May 254
CLARKE JOHN K0001209191-21-035836
SEC(opens sec.gov)
Apr 294
CLARKE JOHN K0001209191-21-029117
SEC(opens sec.gov)
Sep 34
CLARKE JOHN K0001209191-20-049578
SEC(opens sec.gov)
Aug 284
CLARKE JOHN K0001209191-20-048698
SEC(opens sec.gov)
May 84
CLARKE JOHN K0001209191-20-027949
SEC(opens sec.gov)
May 104
CLARKE JOHN K0001209191-19-029005
SEC(opens sec.gov)
Jun 224
CLARKE JOHN K0001735276-18-000028
SEC(opens sec.gov)
Jun 44
CLARKE JOHN K0001735276-18-000006
SEC(opens sec.gov)

Companies

Address

300 THIRD STREET

CAMBRIDGE, MA, 02142